HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ma, Z. Articles by Turk, J. Search for Related Content PubMed PubMed Citation Articles by Ma, Z. Articles by Turk, J. Social Bookmarking                      What's this?

Volume 272, Number 28, Issue of July 11, 1997 pp. 17827-17835
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Interleukin-1 Reduces the Glycolytic Utilization of Glucose by Pancreatic Islets and Reduces Glucokinase mRNA Content and Protein Synthesis by a Nitric Oxide-dependent Mechanism

(Received for publication, April 2, 1997)

From the Mass Spectrometry Resource, Divisions of Endocrinology, Diabetes, and Metabolism and Laboratory Medicine, Departments of Medicine and Pathology, Washington University School of Medicine, St. Louis, Missouri 63110

Culture of rat pancreatic islets with interleukin-1 (IL-1) results in up-regulation of the inducible isoform of nitric oxide synthase and overproduction of nitric oxide (NO). This is associated with reversible inhibition of both glucose-induced insulin secretion and islet glucose oxidation, and these effects are prevented by the inducible nitric oxide synthase inhibitor N^G-monomethylarginine. IL-1 also induces accumulation of nonesterified arachidonic acid in islets by an NO-dependent mechanism, and one potential explanation for that effect would involve an IL-1-induced enhancement of islet glycolytic flux. We have therefore examined effects of IL-1 on islet glycolytic utilization of glucose and find that culture of islets with IL-1 in medium containing 5.5 mM glucose results in suppression of islet glucose utilization subsequently measured at glucose concentrations between 6 and 18 mM. The IL-1-induced suppression of islet glucose utilization is associated with a decline in islet glucokinase mRNA content, as determined by competitive reverse transcriptase-polymerase chain reaction, and in glucokinase protein synthesis, as determined by immuoprecipitation experiments, and all of these effects are prevented by N^G-monomethylarginine. These findings suggest that IL-1 can down-regulate islet glucokinase, which is the primary component of the islet glucose-sensor apparatus, by an NO-dependent mechanism. Because reductions in islet glucokinase levels are known to cause a form of type II diabetes mellitus, these observations raise the possibility that factors which increase islet NO levels might contribute to development of glucose intolerance.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Kutlu, A. K. Cardozo, M. I. Darville, M. Kruhoffer, N. Magnusson, T. Orntoft, and D. L. Eizirik Discovery of Gene Networks Regulating Cytokine-Induced Dysfunction and Apoptosis in Insulin-Producing INS-1 Cells Diabetes, November 1, 2003; 52(11): 2701 - 2719. [Abstract] [Full Text] [PDF]

				D. R. Laybutt, H. Kaneto, W. Hasenkamp, S. Grey, J.-C. Jonas, D. C. Sgroi, A. Groff, C. Ferran, S. Bonner-Weir, A. Sharma, et al. Increased Expression of Antioxidant and Antiapoptotic Genes in Islets That May Contribute to {beta}-Cell Survival During Chronic Hyperglycemia Diabetes, February 1, 2002; 51(2): 413 - 423. [Abstract] [Full Text] [PDF]

				E. Paxinou, M. Weisse, Q. Chen, J. M. Souza, C. Hertkorn, M. Selak, E. Daikhin, M. Yudkoff, G. Sowa, W. C. Sessa, et al. Dynamic regulation of metabolism and respiration by endogenously produced nitric oxide protects against oxidative stress PNAS, September 13, 2001; (2001) 201293198. [Abstract] [Full Text] [PDF]

				S. T. Grey, M. B. Arvelo, W. Hasenkamp, F. H. Bach, and C. Ferran A20 Inhibits Cytokine-induced Apoptosis and Nuclear Factor {kappa}B-dependent Gene Activation in Islets J. Exp. Med., October 18, 1999; 190(8): 1135 - 1146. [Abstract] [Full Text] [PDF]

				G. Kwon, G. Xu, C. A. Marshall, and M. L. McDaniel Tumor Necrosis Factor alpha -induced Pancreatic beta -Cell Insulin Resistance Is Mediated by Nitric Oxide and Prevented by 15-Deoxy-Delta 12,14-prostaglandin J2 and Aminoguanidine. A ROLE FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR gamma  ACTIVATION AND iNOS EXPRESSION J. Biol. Chem., June 25, 1999; 274(26): 18702 - 18708. [Abstract] [Full Text] [PDF]

				S. Ramanadham, F.-F. Hsu, A. Bohrer, Z. Ma, and J. Turk Studies of the Role of Group VI Phospholipase A2 in Fatty Acid Incorporation, Phospholipid Remodeling, Lysophosphatidylcholine Generation, and Secretagogue-induced Arachidonic Acid Release in Pancreatic Islets and Insulinoma Cells J. Biol. Chem., May 14, 1999; 274(20): 13915 - 13927. [Abstract] [Full Text] [PDF]

				J. Ye and S. G. Laychock A Protective Role for Heme Oxygenase Expression in Pancreatic Islets Exposed to Interleukin-1{beta} Endocrinology, October 1, 1998; 139(10): 4155 - 4163. [Abstract] [Full Text] [PDF]

				E. Paxinou, M. Weisse, Q. Chen, J. M. Souza, C. Hertkorn, M. Selak, E. Daikhin, M. Yudkoff, G. Sowa, W. C. Sessa, et al. Dynamic regulation of metabolism and respiration by endogenously produced nitric oxide protects against oxidative stress PNAS, September 25, 2001; 98(20): 11575 - 11580. [Abstract] [Full Text] [PDF]